Recommended Topic Related To:

Fluorescite

"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...

Fluorescite

PATIENT INFORMATION

Skin will attain a temporary yellowish discoloration. Urine attains a bright yellow color.

Discoloration of the skin usually fades in 6 to 12 hours and usually fades in urine in 24 to 36 hours.

Last reviewed on RxList: 10/7/2008
This monograph has been modified to include the generic and brand name in many instances.

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.